- Total revenue reached $14.0M in Q3 2026, driven by 17% growth in Surgical Aesthetics.
- Diluted EPS was $(0.04) with an operating loss, while cash reserves fell to $25.8M.
- Full-year 2026 revenue guidance reaffirmed at $59.0M to $60.0M.
Why is $APYX moving today? · SEC 8-K archive
$APYX SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $APYX: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $APYX filing catalyst
Why did $APYX trigger an AI stock catalyst alert?
$APYX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Apyx Medical Q3 Revenue Rises to $14.0M, Reaffirms FY26 Guidance. Key points: - Total revenue reached $14.0M in Q3 2026, driven by 17% growth in Surgical Aesthetics. - Diluted EPS was $(0.04) with an operating loss, while cash reserves fell to $25.8M. - Full-year 2026 revenue guidance reaffirmed at $59.0M to $60.0M.
How did $APYX stock react after the SEC filing?
After the SEC 8-K for $APYX, observed market reaction: T0 price $2.59. Past moves do not guarantee future results.
Where can I get real-time $APYX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $APYX via Telegram and the VIP Web Terminal from €10/month.